Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-09

Clinical Trial Update: Efficacy and Safety of Seroquel and Lithium as Monotherapy in Acute Mania Treatment in Bipolar Disorder Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing the efficacy and safety of quetiapine (Seroquel) and lithium as monotherapy for acute mania in bipolar disorder; the study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lithium (Lithium carbonate)
  • SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Mania, Bipolar Disorder | Phase 3 | Status: COMPLETED